Literature DB >> 26530135

miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation.

S E M Heinsbroek1, M L Squadrito2, R Schilderink1, F W Hilbers1, C Verseijden1, M Hofmann1, A Helmke1, L Boon3, M E Wildenberg1, J J T H Roelofs4, C Y Ponsioen1, C P Peters1, A A Te Velde1, S Gordon5, M De Palma2, W J de Jonge1.   

Abstract

MiR-511-3p is embedded in intron 5 of the CD206/MRC1 gene Mrc1, expressed by macrophage and dendritic cell populations. CD206 and miR-511-3p expression are co-regulated, and their contribution to intestinal inflammation is unclear. We investigated their roles in intestinal inflammation in both mouse and human systems. Colons of CD206-deficient mice displayed normal numbers of monocytes, macrophage, and dendritic cells. In experimental colitis, CD206-deficient mice had attenuated inflammation compared with wild-type (WT) mice. However, neither a CD206 antagonist nor a blocking antibody reproduced this phenotype, suggesting that CD206 was not involved in this response. Macrophages isolated from CD206-deficient mice had reduced levels of miR-511-3p and Tlr4 compared with WT, which was associated with reduced pro-inflammatory cytokine production upon lipopolysaccharides (LPS) and fecal supernatant stimulation. Macrophages overexpressing miR-511-3p showed 50% increase of Tlr4 mRNA, whereas knockdown of miR-511-3p reduced Tlr4 mRNA levels by 60%, compared with scrambled microRNA (miRNA)-transduced cells. Response to anti-tumor necrosis factor (TNF) treatment has been associated with elevated macrophage CD206 expression in the mucosa. However, in colon biopsies no statistically significant change in miR-511-3p was detected. Taken together, our data show that miR-511-3p controls macrophage-mediated microbial responses and is involved in the regulation of intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26530135     DOI: 10.1038/mi.2015.113

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  44 in total

1.  Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.

Authors:  Anne Christine W Vos; Manon E Wildenberg; Ingrid Arijs; Marjolijn Duijvestein; Auke P Verhaar; Gert de Hertogh; Séverine Vermeire; Paul Rutgeerts; Gijs R van den Brink; Daniel W Hommes
Journal:  Inflamm Bowel Dis       Date:  2011-09-20       Impact factor: 5.325

2.  The microRNA Registry.

Authors:  Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

3.  The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation.

Authors:  Sven Burgdorf; Veronika Lukacs-Kornek; Christian Kurts
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

4.  Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells.

Authors:  Mario Leonardo Squadrito; Caroline Baer; Frédéric Burdet; Claudio Maderna; Gregor D Gilfillan; Robert Lyle; Mark Ibberson; Michele De Palma
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

5.  Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.

Authors:  Masayuki Fukata; Kathrin S Michelsen; Rajaraman Eri; Lisa S Thomas; Bing Hu; Katie Lukasek; Cynthia C Nast; Juan Lechago; Ruliang Xu; Yoshikazu Naiki; Antoine Soliman; Moshe Arditi; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05       Impact factor: 4.052

6.  Normal host defense during systemic candidiasis in mannose receptor-deficient mice.

Authors:  Sena J Lee; Nai-Ying Zheng; Monica Clavijo; Michel C Nussenzweig
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  The beneficial effect of Rheum tanguticum polysaccharide on protecting against diarrhea, colonic inflammation and ulceration in rats with TNBS-induced colitis: the role of macrophage mannose receptor in inflammation and immune response.

Authors:  Li Liu; Zhenjun Guo; Zhengguang Lv; Yang Sun; Wei Cao; Rong Zhang; Zhenguo Liu; Chen Li; Shousong Cao; Qibing Mei
Journal:  Int Immunopharmacol       Date:  2008-05-28       Impact factor: 4.932

Review 8.  Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2008-03       Impact factor: 5.325

Review 9.  Influence of the mannose receptor in host immune responses.

Authors:  Umut Gazi; Luisa Martinez-Pomares
Journal:  Immunobiology       Date:  2009-01-21       Impact factor: 3.144

10.  The mannose receptor mediates dengue virus infection of macrophages.

Authors:  Joanna L Miller; Barend J M de Wet; Barend J M deWet; Luisa Martinez-Pomares; Catherine M Radcliffe; Raymond A Dwek; Pauline M Rudd; Siamon Gordon
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  17 in total

1.  miR-511-3p protects against cockroach allergen-induced lung inflammation by antagonizing CCL2.

Authors:  Danh C Do; Jie Mu; Xia Ke; Karan Sachdeva; Zili Qin; Mei Wan; Faoud T Ishmael; Peisong Gao
Journal:  JCI Insight       Date:  2019-10-17

2.  Mannose receptor modulates macrophage polarization and allergic inflammation through miR-511-3p.

Authors:  Yufeng Zhou; Danh C Do; Faoud T Ishmael; Mario Leonardo Squadrito; Ho Man Tang; Ho Lam Tang; Man-Hsun Hsu; Lipeng Qiu; Changjun Li; Yongqing Zhang; Kevin G Becker; Mei Wan; Shau-Ku Huang; Peisong Gao
Journal:  J Allergy Clin Immunol       Date:  2017-06-17       Impact factor: 10.793

Review 3.  Macrophage polarization and allergic asthma.

Authors:  Arjun Saradna; Danh C Do; Shruthi Kumar; Qing-Ling Fu; Peisong Gao
Journal:  Transl Res       Date:  2017-10-07       Impact factor: 7.012

Review 4.  MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Victoria Piurowski; Brooke Rigot; Carlo M Croce
Journal:  Curr Opin Pharmacol       Date:  2017-11-15       Impact factor: 5.547

5.  Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.

Authors:  Takao Tsurubuchi; Makoto Shirakawa; Wataru Kurosawa; Kayo Matsumoto; Risa Ubagai; Hiroshi Umishio; Yasuyo Suga; Junko Yamazaki; Akihiro Arakawa; Yutaka Maruyama; Takuya Seki; Yusuke Shibui; Fumiyo Yoshida; Alexander Zaboronok; Minoru Suzuki; Yoshinori Sakurai; Hiroki Tanaka; Kei Nakai; Eiichi Ishikawa; Akira Matsumura
Journal:  Cells       Date:  2020-05-21       Impact factor: 6.600

6.  Zika virus tropism during early infection of the testicular interstitium and its role in viral pathogenesis in the testes.

Authors:  Konstantin A Tsetsarkin; Joshua A Acklin; Guangping Liu; Heather Kenney; Natalia L Teterina; Alexander G Pletnev; Jean K Lim
Journal:  PLoS Pathog       Date:  2020-07-02       Impact factor: 6.823

7.  PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves.

Authors:  Chyntia Carolina Díaz Acosta; André Alves Dias; Thabatta Leal Silveira Andrezo Rosa; Leonardo Ribeiro Batista-Silva; Patricia Sammarco Rosa; Thiago Gomes Toledo-Pinto; Fabrício da Mota Ramalho Costa; Flávio Alves Lara; Luciana Silva Rodrigues; Katherine Antunes Mattos; Euzenir Nunes Sarno; Patrícia Torres Bozza; Christophe Guilhot; Márcia de Berrêdo-Pinho; Maria Cristina Vidal Pessolani
Journal:  PLoS Pathog       Date:  2018-07-06       Impact factor: 6.823

8.  Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

Authors:  Ying Cui; Le-Gao Chen; Hai-Bo Yao; Jun Zhang; Ke-Feng Ding
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

Review 9.  MicroRNAs: At the Interface of Metabolic Pathways and Inflammatory Responses by Macrophages.

Authors:  Morgan C Nelson; Ryan M O'Connell
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

Review 10.  MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers.

Authors:  Yixin Yang; Christopher Alderman; Ayoub Sehlaoui; Yuan Xiao; Wei Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.